Literature DB >> 31150762

Glioma stages prediction based on machine learning algorithm combined with protein-protein interaction networks.

Bing Niu1, Chaofeng Liang2, Yi Lu3, Manman Zhao3, Qin Chen4, Yuhui Zhang5, Linfeng Zheng6, Kuo-Chen Chou7.   

Abstract

BACKGROUND: Glioma is the most lethal nervous system cancer. Recent studies have made great efforts to study the occurrence and development of glioma, but the molecular mechanisms are still unclear. This study was designed to reveal the molecular mechanisms of glioma based on protein-protein interaction network combined with machine learning methods. Key differentially expressed genes (DEGs) were screened and selected by using the protein-protein interaction (PPI) networks.
RESULTS: As a result, 19 genes between grade I and grade II, 21 genes between grade II and grade III, and 20 genes between grade III and grade IV. Then, five machine learning methods were employed to predict the gliomas stages based on the selected key genes. After comparison, Complement Naive Bayes classifier was employed to build the prediction model for grade II-III with accuracy 72.8%. And Random forest was employed to build the prediction model for grade I-II and grade III-VI with accuracy 97.1% and 83.2%, respectively. Finally, the selected genes were analyzed by PPI networks, Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, and the results improve our understanding of the biological functions of select DEGs involved in glioma growth. We expect that the key genes expressed have a guiding significance for the occurrence of gliomas or, at the very least, that they are useful for tumor researchers.
CONCLUSION: Machine learning combined with PPI networks, GO and KEGG analyses of selected DEGs improve our understanding of the biological functions involved in glioma growth.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ANN; Couple naïve Bayes; DEGs; GO; KEGG; Machine learning; PPI networks; Random forest; SVM

Year:  2019        PMID: 31150762     DOI: 10.1016/j.ygeno.2019.05.024

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  7 in total

Review 1.  Glioma-Targeted Therapeutics: Computer-Aided Drug Design Prospective.

Authors:  Preantha Poonan; Clement Agoni; Mahmoud A A Ibrahim; Mahmoud E S Soliman
Journal:  Protein J       Date:  2021-09-29       Impact factor: 2.371

Review 2.  Emerging landscape of molecular interaction networks:Opportunities, challenges and prospects.

Authors:  Gauri Panditrao; Rupa Bhowmick; Chandrakala Meena; Ram Rup Sarkar
Journal:  J Biosci       Date:  2022       Impact factor: 2.795

3.  Gene biomarker prediction in glioma by integrating scRNA-seq data and gene regulatory network.

Authors:  Guimin Qin; Longting Du; Yuying Ma; Yu Yin; Liming Wang
Journal:  BMC Med Genomics       Date:  2021-12-04       Impact factor: 3.063

Review 4.  Research Progress of Gliomas in Machine Learning.

Authors:  Yameng Wu; Yu Guo; Jun Ma; Yu Sa; Qifeng Li; Ning Zhang
Journal:  Cells       Date:  2021-11-15       Impact factor: 6.600

5.  Identification of protein-protein interaction associated functions based on gene ontology and KEGG pathway.

Authors:  Lili Yang; Yu-Hang Zhang; FeiMing Huang; ZhanDong Li; Tao Huang; Yu-Dong Cai
Journal:  Front Genet       Date:  2022-09-12       Impact factor: 4.772

6.  Predictive Role of the Apparent Diffusion Coefficient and MRI Morphologic Features on IDH Status in Patients With Diffuse Glioma: A Retrospective Cross-Sectional Study.

Authors:  Jun Zhang; Hong Peng; Yu-Lin Wang; Hua-Feng Xiao; Yuan-Yuan Cui; Xiang-Bing Bian; De-Kang Zhang; Lin Ma
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

Review 7.  Making Sense of Genetic Information: The Promising Evolution of Clinical Stratification and Precision Oncology Using Machine Learning.

Authors:  Mahaly Baptiste; Sarah Shireen Moinuddeen; Courtney Lace Soliz; Hashimul Ehsan; Gen Kaneko
Journal:  Genes (Basel)       Date:  2021-05-12       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.